Klok (2020)
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
https://doi.org/10.1016/j.thromres.2020.04.041
https://www.thrombosisresearch.com/article/S0049-3848(20)30157-2/pdf
Treatment
Concomitant medication (Treated with anticoagulats vs. Not received)
COVID-19 (death)
Hazard ratio: 0.790 (0.350-1.800) Univariate analysis

the Netherlands

Retrospective observational study

Medical records

184

184 ICU patients with COVID-19

184 IU patients as reported

Median

14 Day


COVID-19 (death)

41

composite outcome of venous thromboembolism (VTE) and arterial thrombotic complications


Treatment

Concomitant medication

therapeutic anticoagulation

Not received

Treated with anticoagulats


Hazard ratio

0.790 (0.350-1.800)

No

No

No

none


none

Poor

No